AI
Friday, January 13, 2017 10:03:05 AM
CEO Steve King speaking 1-18-17 at Immunotherapy World Conf./Miami (replacing Jeff Hutchins)…
Jan17-20 2017: “Phacilitate's Immunotherapy World Conf.”, Miami
”Meet the future of immuno-oncology - Combining science & partnering. Join 850+ senior cell, gene, and immunotherapy executives in Miami for partnering & business opportunities.
http://www.immunotherapyforum.com
Agenda: http://www.immunotherapyforum.com/immunotherapy-world-2017-agenda
Jan18(Day1):
Focus Session2, “IMMUNOTHERAPY: EXTENDING ITS REACH, PREDICTING RESPONSES”
1-18-17 12:30-12:45pm: Stephen King (Pres&CEO, Peregrine), “Turning up the Heat: Phosphatidylserine-Targeting Antibodies Modulate the Tumor Microenvironment & Enhance Checkpoint Blockade”
Jan17-20 2017: “Phacilitate's Immunotherapy World Conf.”, Miami
”Meet the future of immuno-oncology - Combining science & partnering. Join 850+ senior cell, gene, and immunotherapy executives in Miami for partnering & business opportunities.
http://www.immunotherapyforum.com
Agenda: http://www.immunotherapyforum.com/immunotherapy-world-2017-agenda
Jan18(Day1):
Focus Session2, “IMMUNOTHERAPY: EXTENDING ITS REACH, PREDICTING RESPONSES”
1-18-17 12:30-12:45pm: Stephen King (Pres&CEO, Peregrine), “Turning up the Heat: Phosphatidylserine-Targeting Antibodies Modulate the Tumor Microenvironment & Enhance Checkpoint Blockade”
